<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Doug Devens

20 years of diverse medical device experience, including leading companies 3M, Coloplast and Boston Scientific, along with emerging companies. Leadership experience in product development, including championing the process for voice of customer and concept feedback sessions with key thought leaders.
Find me on:

Recent Posts

Q218 US Hemostats and Sealants Market Recap: Revenue Grows

Posted by Doug Devens on 8/29/18 12:04 PM

Baxter, Ethicon and Integra lead the way...

As reported in  SmartTRAK’s Financial Dashboard, the US market for Hemostats and Sealants grew +3.8% YoY in Q218, an increase from +3.1% growth rate overall in Q118. Fibrin sealants continue to lead the way with +7.2% YoY growth in Q218, and thrombin hemostats had a very good quarter with +7.2% growth YoY...

Among the many topics covered in the full Q218 Hemostats and Sealants Market Recap are:

  • Ethicon Continues to Lead Hemostats and Sealants
  • Thrombins Come Back In Hemostats
  • Fibrin Continues To Shine In Sealants
  • Q218 events in the US Hemostats and Sealants Market
Read More

Topics: Biosurgery-Hemostats and Sealants

SmartTRAK Publication Alert: Q118 Hemostats and Sealants Market Recap

Posted by Doug Devens on 6/13/18 9:00 AM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Hemostats and Sealants Market Recap.

Read More

Topics: Biosurgery-Hemostats and Sealants

SmartTRAK Publication Alert: Q118 Surgical Matrices Market Recap

Posted by Doug Devens on 6/11/18 6:16 PM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 US Surgical Matrices Market Recap.

Read More

Topics: Wound Care-Surgical Matrices

SmartTRAK's Final 2017 US Surgical Matrices Market Financial Results

Posted by Doug Devens on 4/4/18 10:27 AM

The US Surgical Matrices Market advanced again in Q417, reaching sales of $338.2MM, up +6.8% YoY, fueled by double-digit growth in allograft breast matrices and biosynthetics hernia matrices.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Surgical Matrices Market Recap and Financial Dashboard.

Among the many topics covered in the Q417/FY17 US Surgical Matrices Market Recap are:

Read More

Topics: Wound Care-Surgical Matrices

SmartTRAK's Final 2017 Hemostats & Sealants Market Financial Results

Posted by Doug Devens on 3/22/18 4:39 PM

The US market for Hemostats and Sealants recovered in Q417, up +5.0% YoY, in line with historic growth rates. While biologic sealants continue to lag, every other segment grew, led by absorbable hemostats and fibrin sealants.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 Hemostats & Sealants Market Recap and Financial Dashboard.

As reported in SmartTRAK’s Financial Dashboard, almost every manufacturer competing in the Hemostats and Sealants market saw revenue growth in Q417/FY17, led by BaxterEthicon and Cryolife in Q417 and by Baxter and Integra for FY17 ...

Read More

Topics: Biosurgery-Hemostats and Sealants

SmartTRAK Publication Alert: Q317 Wound Care Surgical Matrices Quarterly Market Recap

Posted by Doug Devens on 12/19/17 2:04 PM

Q317 US Surgical Matrices Market: Strong Growth Continues in Breast Matrices 

The US Surgical Matrices Market saw growth in Q317 as sales of allografts fueled double-digit growth in breast matrices and biosynthetics offset declines in biologics in hernia repair.

By Doug Devens, Senior Analyst Biosurgery

The US Surgical Matrices market, consisting of hernia repair and breast reconstruction products, continued uneven growth in Q317.  Allergan continued to capture share in the overall market, using its growth in allografts to increase its share.

Read More

Topics: Advanced Wound Care-Surgical Matrices

SmartTRAK Publication Alert: Q317 Hemostats and Sealants Quarterly Market Recap

Posted by Doug Devens on 12/18/17 7:11 PM

Q317 Market Recap Biosurgery Hemostats & Sealants: Supply Chain Disruptions 

By Doug Devens, Senior Analyst Biosurgery

Surprisingly, the US market for Hemostats and Sealants was down vs Q217 and YoY, an anomaly from historic growth rates, primarily due to supply chain disruptions and softness in the thrombin hemostat segment.

Read More

Topics: Biosurgery-Hemostats and Sealants

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts